Novartis To Close R&D Facility In Japan By Year’s End
This article was originally published in PharmAsia News
Executive Summary
The Swiss company Novartis says it will close its research-and-development facility in Japan by the end of 2008. In doing so, Novartis would be joining several other major multinational pharmaceutical manufacturers in closing R&D facilities in the country. The Novartis Tsukuba Research Institute, was established in 1993 to develop new drugs for the company's Japanese subsidiary, Novartis Pharma KK. The Japan R&D work is to be merged with Novartis operations in the United States as part of a cost-cutting move. (Click here for more - may require a subscription